Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies
Solid tumors adopt multiple mechanisms to grow, evade immune responses, and to withstand therapeutic approaches. A major breakthrough in the armamentarium of anti-cancer agents has been the introduction of monoclonal antibodies (mAbs), able to inhibit aberrantly activated pathways and/or to unleash...
Saved in:
Main Authors: | Gabriele Antonarelli (Author), Federica Giugliano (Author), Chiara Corti (Author), Matteo Repetto (Author), Paolo Tarantino (Author), Giuseppe Curigliano (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bispecific Antibodies Progression in Malignant Melanoma
by: Juan Tang, et al.
Published: (2022) -
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors
by: Luigi Liguori, et al.
Published: (2022) -
Principles and current clinical landscape of NK cell engaging bispecific antibody against cancer
by: Tian Huan, et al.
Published: (2023) -
Targeting HER2 in breast cancer: new drugs and paradigms on the horizon
by: Paolo Tarantino, et al.
Published: (2021) -
Bispecific antibodies in cancer immunotherapy
by: Eva Dahlén, et al.
Published: (2018)